Bank of America
WINT

Bank of America’s Windtree Therapeutics Inc WINT Stock Holding History

Bank of America’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,364
Closed -$14K – 7617
2015
Q3 		$14K Hold
3,364
– – ﹤0.01% 6466
2015
Q2 		$32K Buy
+3,364
New +$47.2K ﹤0.01% 6160
2014
Q4 		– Sell
-143
Closed -$4K – 8197
2014
Q3 		$4K Hold
143
– – ﹤0.01% 7643
2014
Q2 		$4K Buy
+143
New +$3.65K ﹤0.01% 7729
2014
Q1 		– Sell
-264
Closed -$8K – 8358
2013
Q4 		$8K Sell
264
-307
-54% -$9.6K ﹤0.01% 7371
2013
Q3 		$16K Buy
571
+514
+902% +$12.5K ﹤0.01% 6996
2013
Q2 		$1K Buy
+57
New +$1.4K ﹤0.01% 7621

Other funds holding WINT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Bank of America's WINT Position: Q2 2017 in Review

Bank of America sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 610 shares — an estimated $1K sold.

Bank of America first reported a position in WINT in Q2 2013 and held it in 16 quarters. The position peaked at $164K in Q2 2013. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • Bank of America reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • Bank of America sold 610 Windtree Therapeutics Inc shares in Q2 2017, an estimated $1K.
  • Bank of America first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 16 quarters.
  • Bank of America's Windtree Therapeutics Inc position peaked at $164K in Q2 2013.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Bank of America's 13F filing for Q2 2017, filed 14 Aug 2017.